CIC
IDXX icon

Chilton Investment Company’s Idexx Laboratories IDXX Stock Holding History

Chilton Investment Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.44M Sell
15,027
-33
-0.2% -$21.2K 0.2% 53
2025
Q4 		$10.2M Buy
15,060
+28
+0.2% +$19.1K 0.21% 51
2025
Q3 		$9.6M Sell
15,032
-551
-4% -$334K 0.2% 50
2025
Q2 		$8.36M Sell
15,583
-3,249
-17% -$1.55M 0.19% 47
2025
Q1 		$7.91M Sell
18,832
-4,847
-20% -$2.1M 0.19% 45
2024
Q4 		$9.79M Sell
23,679
-143
-0.6% -$62.7K 0.25% 46
2024
Q3 		$12M Sell
23,822
-405
-2% -$197K 0.32% 41
2024
Q2 		$11.8M Sell
24,227
-40
-0.2% -$20.1K 0.33% 39
2024
Q1 		$13.1M Buy
24,267
+14
+0.1% +$7.65K 0.36% 40
2023
Q4 		$13.5M Sell
24,253
-38
-0.2% -$17.8K 0.4% 40
2023
Q3 		$10.6M Sell
24,291
-41
-0.2% -$20.4K 0.34% 43
2023
Q2 		$12.2M Hold
24,332
– – 0.36% 39
2023
Q1 		$12.2M Sell
24,332
-323
-1% -$155K 0.38% 34
2022
Q4 		$10.1M Sell
24,655
-640
-3% -$248K 0.31% 37
2022
Q3 		$8.24M Sell
25,295
-1
-0% -$367 0.26% 36
2022
Q2 		$8.87M Hold
25,296
– – 0.25% 40
2022
Q1 		$13.8M Sell
25,296
-12
-0% -$6.31K 0.33% 32
2021
Q4 		$16.7M Sell
25,308
-373
-1% -$234K 0.35% 34
2021
Q3 		$16M Sell
25,681
-114
-0.4% -$76.6K 0.39% 36
2021
Q2 		$16.3M Sell
25,795
-193
-0.7% -$107K 0.41% 38
2021
Q1 		$12.7M Sell
25,988
-5
-0% -$2.5K 0.35% 38
2020
Q4 		$13M Sell
25,993
-311
-1% -$139K 0.37% 36
2020
Q3 		$10.3M Hold
26,304
– – 0.3% 37
2020
Q2 		$8.69M Hold
26,304
– – 0.29% 41
2020
Q1 		$6.37M Sell
26,304
-148,426
-85% -$38.7M 0.24% 45
2019
Q4 		$45.6M Sell
174,730
-66,583
-28% -$17.5M 1.46% 23
2019
Q3 		$65.6M Sell
241,313
-9,973
-4% -$2.78M 2.19% 20
2019
Q2 		$69.2M Sell
251,286
-12,134
-5% -$2.99M 2.28% 18
2019
Q1 		$58.9M Sell
263,420
-8,971
-3% -$1.85M 2.07% 20
2018
Q4 		$50.7M Buy
272,391
+2,060
+0.8% +$422K 1.85% 24
2018
Q3 		$67.5M Buy
270,331
+964
+0.4% +$234K 2.22% 16
2018
Q2 		$58.7M Buy
269,367
+25,287
+10% +$5.21M 2.06% 17
2018
Q1 		$46.7M Sell
244,080
-15,962
-6% -$2.95M 1.8% 22
2017
Q4 		$40.7M Buy
260,042
+36,459
+16% +$5.74M 1.57% 27
2017
Q3 		$34.8M Buy
223,583
+68,662
+44% +$10.9M 1.34% 30
2017
Q2 		$25M Buy
154,921
+37,880
+32% +$6.15M 0.96% 37
2017
Q1 		$18.1M Sell
117,041
-255,942
-69% -$35.3M 0.7% 38
2016
Q4 		$43.7M Sell
372,983
-254,422
-41% -$29M 1.77% 21
2016
Q3 		$70.7M Sell
627,405
-371,446
-37% -$39.1M 2.76% 17
2016
Q2 		$92.8M Sell
998,851
-8,939
-0.9% -$768K 3.29% 12
2016
Q1 		$78.9M Sell
1,007,790
-219,209
-18% -$15.8M 2.9% 17
2015
Q4 		$89.5M Sell
1,226,999
-284,343
-19% -$20.3M 3.14% 11
2015
Q3 		$112M Buy
1,511,342
+11,789
+0.8% +$844K 3.99% 6
2015
Q2 		$96.2M Buy
1,499,553
+1,138,337
+315% +$78.8M 3.53% 7
2015
Q1 		$27.9M Buy
361,216
+345,932
+2,263% +$26.9M 0.99% 32
2014
Q4 		$1.13M Sell
15,284
-3,236
-17% -$227K 0.04% 119
2014
Q3 		$1.09M Buy
18,520
+14,698
+385% +$929K 0.04% 122
2014
Q2 		$255K Sell
3,822
-3,876
-50% -$246K 0.01% 112
2014
Q1 		$467K Hold
7,698
– – 0.01% 133
2013
Q4 		$409K Buy
+7,698
New +$405K 0.01% 143

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chilton Investment Company's IDXX Position: Q1 2026 in Review

Chilton Investment Company reduced its Idexx Laboratories (IDXX) stake by 0.22% in Q1 2026, selling an estimated $21.2K and leaving 15,027 shares worth $8.44M. The position accounts for 0.2% of the portfolio, ranked #53.

Chilton Investment Company first reported a position in IDXX in Q4 2013 and has held it in 50 quarters since. The position peaked at $112M in Q3 2015. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Chilton Investment Company held 15,027 shares of Idexx Laboratories worth $8.44M as of Q1 2026.
  • Chilton Investment Company sold 33 Idexx Laboratories shares in Q1 2026, an estimated $21.2K.
  • Idexx Laboratories made up 0.2% of Chilton Investment Company's portfolio in Q1 2026, its #53 holding.
  • Chilton Investment Company first reported a position in Idexx Laboratories in Q4 2013 and has held it in 50 quarters since.
  • Chilton Investment Company's Idexx Laboratories position peaked at $112M in Q3 2015.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.